MP
ZURAW

Mangrove Partners’s Zura Bio Limited Warrants ZURAW Stock Holding History

Mangrove Partners’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,951
Closed -$286K – 509
2021
Q4 		$286K Buy
+28,951
New +$15.6K 0.02% 484

Other funds holding ZURAW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Mangrove Partners's ZURAW Position: Q1 2022 in Review

Mangrove Partners sold out of Zura Bio Limited Warrants (ZURAW) in Q1 2022, closing a stake of 28,951 shares — an estimated $286K sold.

Mangrove Partners first reported a position in ZURAW in Q4 2021 and held it in 1 quarter. The position peaked at $286K in Q4 2021. 21 funds tracked by Wall St. Rank hold ZURAW as of Q1 2022.

  • Mangrove Partners reported no remaining Zura Bio Limited Warrants position as of Q1 2022 after selling out during the quarter.
  • Mangrove Partners sold 28,951 Zura Bio Limited Warrants shares in Q1 2022, an estimated $286K.
  • Mangrove Partners first reported a position in Zura Bio Limited Warrants in Q4 2021 and held it in 1 quarter.
  • Mangrove Partners's Zura Bio Limited Warrants position peaked at $286K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q1 2022.

Based on Mangrove Partners's 13F filing for Q1 2022, filed 16 May 2022.